Dendritic cells (DC) are described as "nature's adjuvant," since they have the capacity to sensitize T cells in vivo upon first encounter with the antigen. The potent accessory properties of DC appear to develop sequentially. In particular, the ability to process antigens and to sensitize naive T cells develops in sequence, a process termed "maturation" that is well described in vitro. Here, we obtain evidence for maturation in vivo in response to the bacterial product lipopolysaccharide (LPS). Before LPS treatment, many DC are found at the margin between the red and white pulp. These cells lack the M342 and DEC-205 markers, but process soluble proteins effectively. 6 h after LPS, DC with the M342 and DEC-205 markers are found in increased numbers in the T cell areas. These cells have a reduced capacity to process proteins, but show increases in the B7 costimulator and T cell stimulatory capacity. 48 h after LPS, the number of DC in the spleen is reduced markedly. We interpret these findings to mean that LPS can cause DC in the marginal zone to mature and to migrate into and then out of the T cell areas.
Summary
Dendritic cells (DC) are described as "nature's adjuvant," since they have the capacity to sensitize T cells in vivo upon first encounter with the antigen. The potent accessory properties of DC appear to develop sequentially. In particular, the ability to process antigens and to sensitize naive T cells develops in sequence, a process termed "maturation" that is well described in vitro. Here, we obtain evidence for maturation in vivo in response to the bacterial product lipopolysaccharide (LPS). Before LPS treatment, many DC are found at the margin between the red and white pulp. These cells lack the M342 and DEC-205 markers, but process soluble proteins effectively. 6 h after LPS, DC with the M342 and DEC-205 markers are found in increased numbers in the T cell areas. These cells have a reduced capacity to process proteins, but show increases in the B7 costimulator and T cell stimulatory capacity. 48 h after LPS, the number of DC in the spleen is reduced markedly. We interpret these findings to mean that LPS can cause DC in the marginal zone to mature and to migrate into and then out of the T cell areas.
O
Ptimal activation of T lymphocytes depends on T C R interactions with peptide/MHC complexes in conjunction with costimulatory signals that are typically delivered by the same APC. The costimulatory signal is antigen nonspecific, and is delivered by CD28 or CTLA4 on T cells that interact with a ligand, B7-1 (CD80) or B7-2 (CD86), that is present on the APC (1) . The role of costimulatory molecules has been clearly demonstrated by studies showing that antigenic stimulation of T cells in vitro in the absence of costimulation leads to aborted T cell proliferation and the development of functional unresponsiveness or clonal anergy of T cells (2) . Injection of CTLA4Ig, a soluble form of the extracellular domain of CTLA-4 with high avidity for B7-1 and B7-2, suppresses T cell-dependent antibody responses in vivo (3) . CTLA4Ig is also capable of blocking in vitro proliferation in assays ofalloreactivity (4, 5) , as well as preventing xenograft rejection (6) and prolonging allograft rejection (7, 8) . These data show that B7/CD28-CTLA4 activation pathways play an important role in regulating in vivo T cell responses.
Among the population of APC, which in the mouse comprises dendritic cells (DC) ~, B lymphocytes, and macrophages, DC appear to have the unique capacity to acti1Abbreviations used in this paper: BR, blocking reagent; DC, dendritic cells; SEB, staphylococcal enterotoxin B.
vate naive T cells (9) . In vitro, they are essential to trigger a primary antibody response (10) and to generate antiviral CTL (11, 12) , and they strongly stimulate CD4 + (13) and CD8 + (14) cells in the primary mixed leukocyte reaction. In vivo, DC appear to play a major role in initiating various T cell immune responses, such as contact sensitivity (15) (16) (17) and allograft rejection (18) (19) (20) (21) . DC pulsed extracorporeally can efficiently induce cellular (22) and T cell-dependent humoral (23, 24) responses in mice. The property of isolated D C to sensitize quiescent T cells upon the first encounter with the antigen correlates with their capacity to express very high levels of antigen/MHC peptides, as well as B7-1 and B7-2 costimulatory molecules (5, 25, 26) .
The first step of the immune response leading to efficient activation of antigen-specific, naive T cells in situ is still poorly understood. DC are likely to be the adjuvant of the immune system in vivo. DC are motile and efficiently cluster T cells, are widely distributed in tissues, carry antigens that are administered intradermally or intravenously, and circulate through lymph or blood probably in route to lymphoid organs (for review see reference 9). The analysis of cryostat sections (26) , however, revealed that B7-1 and B7-2 staining was weak or negative in most nonlymphoid organs, but strong in select sites in lymphoid organs. In particular, in the spleen, both MHC class II and B7-2 were expressed strongly on dendritic profiles in the T cell re-gions that occupy the center of the white pulp, but not in marginal zone where DC are abundant, and they carry high levels of the CDllc leukocyte integrin. Furthermore, the expression of both B7 molecules is weak on DC that are freshly isolated from the spleen, but is strongly upregulated in vitro, without intentional stimulation (26, 27) . This process of maturation is characterized by the upregulation of the T cell-sensitizing function and the downregulation of the antigen-processing capacity during short-term culture (26) (27) (28) (29) (30) . These observations indicate that DC do not display constitutive costimulatory function in situ, and suggest that they may mature into potent accessory cells during the early sensitization phase of immunity.
In this paper, we show that systemic administration of endotoxin (LPS) induces the migration of most splenic DC from the marginal zone to the T cell areas within 4-6 h. This movement parallels a maturation process, as assessed by downregulation of processing capacity and upregulation ofimmunostimulatory properties. Unexpectedly, 48 h after LPS injection, the number of splenic DC decreased markedly, an observation that correlates with an impaired capacity to activate naive T lymphocytes in vitro and in vivo.
These data show that DC function is regulated by microbial products. LPS induces DC migration and maturation in vivo, resulting in colocalization of potent DC and T lymphocytes. The subsequent loss of DC after activation may be part of a negative feedback mechanism that controls in vivo inflammatory responses that may cause severe tissue damage.
Materials and Methods

Mice
Female BALB/c (H-2 d) and CBA/J (H-2k), 6-8-wk old, were purchased from Charles P, iver Wiga (Sulzfeld, Germany) and maintained in our own pathogen-free facility.
Reagents and Antibodies
LPS from Escherichia coli (serotype 055:B5) was purchased from Difco Laboratories (Detroit, MI). Purified exotoxin staphylococcal enterotoxin B (SEB) was purchased from Toxin Technology, Inc. (Sarasota, FL). Hamster mAb 37.51 to murine CD28 and control mAb F531 (kindly provided by J. Allison, University of California, Berkeley, CA; 31) were used at 1/10,000 dilution of ascitic fluids. Hamster mAb 145-2Cll to mouse CD3e (32) was purified in our laboratory. Myoglobin from sperm whale skeletal muscle was obtained from Fluka Chemie AG (Buchs, Switzerland). Pork insulin was purchased from Sigma Immunochemicals (St. Louis, MO).
In Vivo Treatment
Endotoxinlnjection. BALB/c mice were injected intravenously into the lateral tail vein with 25 p,g LPS solubilized in pyrogen-free NaCI 0.9%. Control animals were injected with the same volume of NaC1.
T Cell Activation In Vivo. LPS-treated and control BALB/c mice were injected with either 50 t*g SEB or 50 txg anti-CD3e solubilized in pyrogen-free NaC1 0.9%. The mice were bled 2 h later, and the sera were assayed for IL-2 content using a standard bioassay using an IL-2-dependent, IL-4-insensitive subclone of the CTL.L line. IFN-~/was quantitated by two-site ELISA using mAbs F1 and Db-1, kindly provided by Dr. Billiau (Katholieke Universiteit Leuven, Leuven, Belgium) and P,H. Van Der Meide (TNO Health Research, P, ijswijk, The Netherlands), respectively.
Cell Lines
The I-Ea-restricted, myoglobin-specific T cell hybridoma 13-26-8-HG.1 (33) was kindly provided by Dr. A. Livingstone (Basel Institute of Immunology, Basel, Switzerland). The I-E arestricted, pork insulin-specific T cell hybridoma B8P4.] C3 (34) was kindly provided by Dr T. Delovitch (John P. Robarts Research Institute, London, Ontario, Canada).
Flow Cytometry
Cells were analyzed by flow cytometry with a FACScan | cytometer (Becton Dickinson & Co., Mountain View, CA). The cells were preincubated or not (see figure legends) with 2.4G2 (a rat anti-mouse Fc receptor mAb) for 10 rain before staining to prevent antibody binding to FcR., and were incubated with fluorescein-coupled mAb 14.4.4 (murine lgG2a anti-I-E a, available through American Type Culture Collection, R.ockville, MD), N418 (hamster antimurine CDllc; 35), 1610A1 (hamster anti-B7-1; 36), GL1 (rat IgG2a anti-B7-2; 37) with PE-coupled CD45K/B220 (rat IgG2a; PharMingen, San Diego, CA) or with biotinylated N418 followed by avidin coupled to PE or with biotinylated CDI 1b/Mac1 (PharMingen) revealed by avidin coupled to fluorescein. Cells were gated according to size and scatter to eliminate dead cells and debris from analysis.
Purification of Low Density Spleen Cells and Fresh DC
Spleens were digested with collagenase (CLSIII; Worthington Biochemical Corp., Freehold, NJ) and separated into low and high density fractions on a BSA gradient (Bovuminar Cohn fraction V powder; Armour Pharmaceutical Co., Tarrytown, NY), according to a procedure described by Crowley et al. (38) . A further purification of fresh DC (without in vitro culture) by enrichment on a Mini Macs column was sometimes performed, according to the manufacturer's recommendations (Miltenyi Biotec GmbH, Bergisch-Gladbach, Germany). In brief, low density spleen cells were incubated with biotinylated N418, washed, and incubated with streptavidin microbeads. Cells were then positively enriched on a Mini Macs column. More than 85% of these cells expressed N418 and MHC class II. For FACS | analysis, a gate was performed on N418-positive cells. 
In Vitro Responses
The complete medium used in all experiments was R.PMI 1640 (Seromed Biochem KG, Berlin, Germany) supplemented with 2% HY ultroser (a serum-free medium supplement purchased from GIBCO BILL, Merelbeke, Belgium) or 10% FCS, penicillin, streptomycin, nonessential aminoacids, sodium pyruvate, 2-ME, and L-glutamine (Flow ICN Biomedicals, Bucks, UK). Splenic T cells were purified by depletion of adherent cells by passage over Sephadex G10 (Pharmacia Bioprocess, Uppsala, Sweden) and complement mediated lysis with a cocktail of anti-APC antibodies. T cells were stimulated with graded doses of SEB in the presence of ~/-irradiated (3,000 rads) spleen cells or fresh DC in round-bottom 96-well plates, or were cultured in the presence of various numbers of'y-irradiated (3,000 rads) allogeneic spleen cells. Cultures were maintained at 37~ in a humidified incubator (7% CO2). The supernatants were collected after 12-48 h of culture, frozen, and assayed for IL-2 content (see above).
Immunohistochemistry
Tissues samples were frozen in isopentane and 12-1~m cryostat sections were prepared. Samples were fixed in neat acetone for 10 min, air-dried, and incubated in PBS containing 0.5% of blocking reagent (BR) from Boehringer for 30 min. Sections were incubated for 20 min with culture supematant of the monoclonal rat anti-mouse antibody 2.4G2 to Fc receptors to prevent nonspecific staining, except when culture supematants were used for primary antibodies. Slides were washed in PBS, incubated for 1 h at room temperature with 10 I~g/ml in PBS-BR 0. Slides were then incubated in a 1:100 dilution of avidinbiotin-peroxidase complex (Vectastain ABC kit; Vector Laboratories, Inc., Burlingame, CA) in PBS-BR 0.5% or goat F(ab')2 anti-rat Ig-peroxidase (POD) (BioSource International, Camarillo, CA) or rabbit F(ab')2 anti-hamster Ig-POD (Rockland Inc., Gilbertsville, PA) for 30 min and washed in PBS. The peroxidase activity was revealed with a solution of diaminobenzidine tetrahydrochloride with or without metal enhancer (DAB tablets, SigrnaFAST; Sigma). The sections were stained for 10 min at room temperature, counterstained with hematoxylin or methyl green, and mounted with Poly-mount (Polysciences Inc., Warrington, PA). The injection of LPS leads to a redistribution of DC markers in the spleen, suggesting that DC have migrated from the marginal zone to the T cell area. Fig. 1 (middle panel) shows serial sections stained with various antibodies.
Most N418-positive (E) cells were detected in association with T cells (H) 6 h after injection of LPS. Adjacent sections of the T cell areas were strongly stained with NLDC-145 (F) and M342 (G) antibodies. 48 h after endotoxin administration (Fig. 1, right panel) , the overall number of splenic DC was strongly reduced, since only few cells in the T cell areas (L) stained with N418 (/), NLDC-145 (J), or M342 (K).
Splenic DC Upregulate MHC Class II and B7 Expression
Early after LPS Injection. Since the expression of M342 and NLDC-145 is weak or absent on freshly isolated DC and increased after culture and maturation in vitro (40, 41), we tested whether LPS could induce DC maturation in vivo. LPS was injected intravenously, and 6 h later, low density spleen cells were enriched for N418 + cells (see Materials and Methods), and the expression of MHC class II and costimulatory molecules (B7.1 and B7.2) was analyzed by FACS | As shown in Fig. 2 , DC isolated from LPS-treated mice displayed increased levels of I-E, B7-1, and B7-2 molecules, as compared to control animals, whereas the expression of CDllc remained unchanged.
LPS Induces Functional Maturation of Splenic DC within a Few Hours.
One of the hallmarks of maturation of DC upon culture in vitro is an increased capacity to sensitize naive T cells and a reciprocal downregulation of the capacity to process protein antigens (26) (27) (28) (29) (30) . To test whether the injection of LPS and the subsequent upregulation of MHC class II and costimulatory molecules on DC were associated with a functional maturation in vivo, splenic DC were purified from naive or LPS-injected animals and immediately tested as accessory cells for the presentation of SEB to syngeneic naive T cells. This superantigen does not require processing and is best presented by DC (42, 43) . As shown in Fig. 3 A, DC enriched from animals that had been injected with LPS 6 h earlier were better activators ofT cells than DC from untreated animals. The increased immuno-
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stimulatory properties of DC from LPS-treated mice were inversely correlated with their capacity to process and present a protein antigen, as assessed by a decreased ability to present insulin to T cell hybridoma (Fig. 3 B) . The capacity of DC to present antigens that do not need processing (SEB or peptides) to T cell hybridoma remained unchanged 6 h after endotoxin administration (data not shown).
LPS Injection Results in the Loss of N418-positive Cells fiom Mouse Spleen after 2 d.
The staining of spleen cryosections ( Fig. 1) revealed that the movement of DC induced early by LPS was followed by a strong reduction ofN418 + cells 48 h later. To further document this observation and to analyze whether the loss of N418 staining in cryosections corresponded to the absence of DC or to a selective loss of N418 marker, we performed immunofluorescence studies on DC-enriched, low-density spleen cells. Fig. 4 represents the contour profiles of cells double-stained with B220 in red, and either N418 or 14-4-4 (anti-I-E d) in green. The data show that low density spleen cells from LPS-injected mice lack the DC population identified as B220-, 14-4-4big h, or B220-, N418 +. The numbers of DC returned to control levels 15 d after endotoxin administration. The APC populations were further stained in unseparated spleens. As shown in Table 1 , LPS-injected mice had reduced numbers of DC, as compared to control animals. By contrast, the numbers of B lyrnphocytes and macrophages were increased in treated animals. Taken together, these data strongly suggest that a single injection of LPS resuits in a selective loss of a major population of splenic DC.
LPS Administration Results in Decreased Capacity to Sensitize Naive T Lymphocytes In Vitro 2 d after Injeca'on.
Since DC appear to have the unique property to activate naive T cells in vitro, we tested the capacity of splenic cells from control and LPS-injected (2 d earlier) mice to induce primary immune responses in vitro. Irradiated spleen cells from LPSinjected animals induced lower IL-2 secretion (Fig. 5 A) by naive, allogeneic T cells than spleen cells from control mice. Equal numbers of spleen cells from control and LPStreated mice stimulated T cells at intermediate levels, suggesting that no mechanism of suppression was induced after control L P S 2 days L P S 15 days LPS injection. Similar data were obtained when syngeneic T lymphocytes were stimulated by SEB in the presence of irradiated spleen cells from both groups (Fig. 5 B) . By contrast, spleen cells from control and endotoxin-injected mice induced similar IL-2 production by CD28-independent T cell hybridoma, which has been shown to respond optimally to T cell receptor ligation in the absence of B7-related costimulatory function (Fig. 5 C) . The addition of antibodies specific for CD28 overcame the APC defect of spleen ceils from LPS-injected mice in the MLP,. (Fig. 5 D) , suggesting that spleen cells from treated animals retained the ability to generate a T C R ligand, but displayed defective costimulatory function.
Injection of LPS Results in Impaired D C Function In Vivo after 48 h.
We next compared the in vivo i m m u n e response of control and LPS-treated mice after injection of DC-dependent or -independent stimuli. Control and LPStreated mice were injected with 50 Ixg SEB or with 25 Izg anti-CD3 mAb (mainly presented by FcR. + B cells or macrophages; 44), and were bled 2 h later to quantify the IL-2 and the I F N -y produced in the sera. Fig. 6 shows that the injection of the T cell mitogen anti-CD3 mAb resulted in high production of IL-2 and I F N -y in both groups. By contrast, the secretion of IL-2 and I F N -y after stimulation by SEB was reduced in mice injected with endotoxin, as compared to untreated animals.
D i s c u s s i o n
The unique capacity of splenic D C to optimally activate naive T cells has been extensively demonstrated in vitro T a b l e and in vivo. In particular, purified DC, pulsed extracorporeally with an antigen, induce specific cellular and humoral responses when injected into syngeneic animals (22, 23) . The adjuvant properties of these cultured DC may depend on a process of maturation that occurs "spontaneously" in vitro during the purification steps (26) (27) (28) (29) (30) . Whether a similar maturation occurs in vivo is still unknown, and it is of major interest to define the conditions that are required for the induction of primary responses in situ. The data presented herein strongly suggest that LPS induces splenic DC maturation in situ, as assessed by upregulation of immunostimulatory properties and downmodulation of processing capacity. These functional changes correlate with a rapid migration of DC to T cell areas, and are followed by the loss of most splenic DC 48 h after LPS injection. The identification of a specific costimulatory signal such as CD28 has focused attention on the functional heterogeneity of APCs. Indeed, optimal activation of naive T cells requires TCP,. occupancy by antigen/MHC complexes and additional signal(s), such as CDS0, CD86, CD40, etc. The expression of CD80 and CD86 varies among the APC populations and seems to correlate with their immunostimulatory properties. DC appear to have some constitutive costimulatory function in several sites in situ, but more typically, this function rapidly develops upon in vitro culture (26). Steinman's group has defined two populations of splenic DC that differ by their localization and phenotype. DC in the T cell regions express MHC class II and B7-2, and are recognized by M342 and NLDC-145 mAbs. DC in the marginal zone are M342-and resemble freshly isolated DC that become M342 + upon culture. These authors suggest that DC from the marginal zone may give rise to M342 + ceils in T cell areas, and this hypothesis is supported by our data showing that DC migrate from the marginal zone to the T cell area and concomitantly mature into M342 +, NLDC-145 + potent accessory cells that express increased levels of class II, B7-1, and B7-2 molecules. We interpret the redistribution of the N418 marker in the spleen 6 h after LPS injection as a migration of DC from the marginal zone to T cell area, although it could result from the loss of a subset of DC present in peripheral areas in spleens and from the recruitment of a distinct subset in the central white pulp. Our hypothesis, however, is supported by the observatiori " that N418 § cells are gradually detected in regions located from the periphery to the center of the white pulp 1.5-4 h after LPS injection (data not shown). The phenotypic changes observed 6 h after LPS injection correlate with increased stimulatory properties, as assessed by enhanced capacity to induce IL-2 secretion by naive T ceils in the presence of SEB. By contrast, the capacity of DC to process native protein such as insulin diminishes after LPS injection, as shown by a decreased ability to trigger IL-2 production by an insulin-specific T cell hybridoma. Collectively, these data strongly suggest that immature DC present in the marginal zone mature after migration to T cell area. It is noteworthy that recent studies (45) have shown that the NLDC-145 mAb recognizes a receptor, termed DEC-205, with a multilectin domain structure that favors efficient capture and presentation of carbohydrate-bearing antigens. The observation that mature DC lose their capacity to process antigens but display increased expression of DEC-205 is intriguing and suggests that DC maintain their capacity to selectively bind carbohydrates. Since these common constituents of microbial cell walls have structures that are distinct from those of carbohydrates of eukaryotic cell surfaces, mature DC may discriminate self from infectious nonself.
Effect of LPS on Splenic Cell Populations
The loss of splenic DC 2 d after endotoxin administration probably reflects a physical disappearance of these cells rather than downmodulation of DC-specific markers, as suggested by the loss of several molecules (class II, C D l l c , NLDC-145, and M342), the movement of N418 § cells early after injection, and the corresponding functional deficiency. In vitro, we showed that the capacity to sensitize naive T cells, a unique property of DC, is impaired in mice that were injected with LPS 2 d earlier. By contrast, spleen cells from treated mice retain the capacity to activate a costimulatory-independent T ceil hybridoma, as well as naive T cells in the presence of an anti-CD28 mAb that mimics B7 engagement. In vivo, activation of T cells by DCdependent T ceil mitogen (SEB) is impaired in LPS-treated mice, as assessed by IL-2 and IFN-~ secretion. By contrast, similar levels of both cytokines are released in the sera of mice after the injection ofa DC-independent stimulus such as anti-CD3 mAb. These observations strongly suggest that the inability to induce primary responses in vitro and in vivo results from the selective loss of cells from the dendritic lineage, which displays some costimulatory function in vivo in the absence of intentional stimulation.
The disappearance of DC could be caused by cell exhaustion, migration out of the spleen, or death (by induction of apoptosis?). Fas ligand and TNF have indeed been found to induce apoptosis in several cell types (46, 47) . A similar loss of DC was induced by LPS in mice displaying defective Fas ligand (our unpublished observations), however, suggesting that the induction of programmed cell death via Fas/FasL is not involved in this phenomenon. Alternatively, mature DC could migrate from the T cell area to the liver, where they would be eliminated, or to the celiac nodes, although there is some evidence that DC do not recirculate from blood to lymph (48) . It would be of major interest to analyze whether this sequence of events is regulated by D C / T interaction in the presence of antigen. The injection of LPS and the antigen in mice expressing a T C R transgene will help to analyze whether antigen-specific, MHC-restricted interaction between DC and T lymphocytes would lead to reciprocal regulation of function and, in particular, may prevent a rapid loss of DC.
The loss of DC after endotoxin administration could be related to the marked depression of cell-mediated immune functions, often associated with septic shock. Indeed, several lines of evidence suggest that the depression in the patient's immune function induced by traumatic injury underlies the development of infection and/or sepsis (49) (50) (51) . The analysis of DC phenotype and function in these patients would help to evaluate the role of DC in the pathogenesis of sepsis.
Our data extend previous studies showing that LPS affects DC populations. Groeneveld and co-workers showed that the number of interdigitating cells was severely decreased in the mouse 48 h after LPS administration (52) . More recently, MacPherson et al. reported that injection of LPS in rats caused an increased release of intestinal DC into lymph (53) . Similarly, Austyn's group showed that injection of LPS induced a loss of DC from the heart, kidneys, and epidermal Langerhans cells (54) . By contrast, LPS aerosolized has been shown to recruit DC into the conducting airways (55) . Of note, a recent report indicates that inflammatory cytokines or exogenous bacterial products modulate the cell-surface phenotype and the immunostimulatory function of human cultured DC (56) .
Migration patterns of DC in the mouse have been extensively studied. Skin painting mice with picryl chloride resulted in an increase in the number of DC in lymph nodes that initiate primary antigen-specific stimulation in vitro and in vivo (57) . Donor-derived DC have been shown to move from the nonlymphoid organs to the recipient's spleen, where they trigger allograft rejection (20) . Labeled mature DC transferred intravenously into a syngeneic host localized in the spleen and the homing was T dependent (58) . After subcutaneous footpad inoculation, DC accumulated in the popliteal nodes (48) . These data show that DC migrate from nonlymphoid tissues to T cell areas of lymphoid organs, and our results suggest that this flux may correlate with a functional maturation.
A large array of cytokines and/or inflammatory mediators (including TNF-ot, IL-1[3, IL-6, IL-12, and GM-CSF) is secreted in mice after LPS injection. We have tested the effect of two cytokines that have been shown to affect DC viability and/or maturation in vitro or in vivo (59-61). The injection of recombinant TNF-o~ induced migration of DC to the T cell area, followed by loss of these cells, whereas GM-CSF did not affect the DC population (De Smedt, T., and M. Moser, manuscript in preparation). Simultaneous injection of neutralizing anti-TNF-or mAb and LPS, however, did not prevent DC movement, suggesting that additional factors induced by LPS may promote DC migration in vivo. Experiments are in progress to test whether IL-1, which has been shown to induce changes in DC function in vitro (62) and promote DC migration in vivo (59) , is involved in this phenomenon.
A direct effect of endotoxin on DC cannot be excluded, however, since treatment of DC by LPS has been shown to lead to increased expression of IL-1, IL-6, and IL-12 mRNA by these cells (63) , as well as to upregulate gene expression and induce release of TNF-oL in DC clones (64) .
The cell population(s) involved in this phenomenon remain(s) to be identified. The injection of LPS in SCID mice results in similar changes in DC (data not shown), suggesting that functional T and B lymphocytes are not required for this phenomenon.
LPS endotoxin from Gram-negative bacteria possesses both harmful and beneficial effects. LPS triggers a host immune response resulting in activation of various cell types and production of multiple cytokines that mediate resistance to the bacteria. An exaggerated inflammatory response to bacterial products, however, may cause irreversible tissue damage leading to death when homeostasis is disrupted. Therefore, it is tempting to speculate that the inhibition of DC function in endotoxemia may constitute a feedback aimed at maintaining the homeostasis of the immune system by inhibiting the function of the most efficient APC in vivo. Such a mechanism would be beneficial to the host by preventing harmful effects of an exaggerated inflammatory response, as well as to the bacteria, by limiting the pathogen-specific immune response. The selective loss of DC after endotoxin administration may provide some insights in bacterial-host relations, and in particular, suggest that bacteria may derive some evolutionary advantage to retain a wall component that is strongly immunogenic, since high doses of LPS may reduce host resistance to the spread of bacteria.
In conclusion, our data support the hypothesis that a critical signal for the initiation of immune responses is provided by microbial infection, as proposed by Janeway (65) . LPS induces costimulatory activity for CD4 + T cells on B lymphocytes and macrophages (66) , and triggers maturation and migration of DC in vivo (this paper). The upregulation of DC function by microbial products and their subsequent movement to T cell areas result in colocalization of T lymphocytes and mature DC that have encountered microbial antigens. Since immature DC have been shown to take up and process antigen, a property that can be lost in mature DC, it is tempting to speculate that most DC in T cell areas would present infectious non-self-antigens. The positive and negative regulation of antigen presentation by microbial agents may help to gain an understanding of how the immune system efficiently eliminates pathogens while avoiding self-reactivity and controls potentially harmful inflammatory responses.
We thank Drs. Jon Austyn, M. Goldman, N. Romani, and R. Steinman for interesting discussions and helpful suggestions; Drs F. Andris, S. Barcy, T. Sornasse, and M. Van Mechelen for valuable help; and G. Dewasme, M. Swaenepoel, F. Tielemans, and P. Veirman for excellent technical assistance.
